Stock Quote

Houston biotech cos. begin clinical trials for cancer, Covid-19 treatments

Both Iterion and Moleculin are moving their drug candidates through the regulatory pipeline.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.